Glucagon was historically considered counterproductive for weight loss because it raises blood glucose
Additional Information Conflict of interest The authors declare the absence of a conflict of interests
Garvey WT, Frias JP, Jastreboff AM et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Thoughtful regulation protects patients far better than driving demand into an unregulated marketplace. Dr
This collection offers recipes that match those evolving needshigh protein, rich in fiber, and light on overly sweet or heavy dishes
Long-term effectiveness and safety of a three-piece acrylic hydrophobic intraocular lens modified with hydroxyethyl-methacrylate: an open-label, 3-year follow-up study